TADAFEM 20

What is TADAFEM 20?

TADAFEM 20 is a tablet-form product manufactured by Sunrise Remedies, positioned as a drug to support female sexual function. It contains tadalafil at a dosage of 20 mg and belongs to the class of phosphodiesterase type 5 inhibitors, abbreviated as PDE-5. In everyday language, the product is sometimes referred to as "Female Cialis," but this name does not imply proven equivalence to the original drug or an officially approved indication for women. Before use, it is necessary to check the registration status, instructions, and legality of the sale of this product in Ukraine.

TADAFEM 20 is produced in the form of tablets for oral administration. Tadalafil affects vascular tone and, in the presence of natural sexual stimulation, can increase blood flow to the pelvic tissues. At the same time, it is not a hormone, an aphrodisiac, or a drug that directly creates sexual desire. The effectiveness of tadalafil specifically for the treatment of female sexual dysfunction remains insufficiently supported by high-quality clinical studies.

Problems with libido, arousal, or satisfaction can be related to stress, menopause, pain, endocrine disorders, chronic diseases, or taking other medications. Therefore, TADAFEM 20 should not be viewed as a universal solution to any intimate difficulties. Before starting use, a doctor's consultation is required, preferably with a gynecologist, sexologist, or family doctor. The specialist will assess the cause of the symptoms, cardiovascular risks, and the appropriateness of this specific approach.

What is TADAFEM 20 prescribed for?

TADAFEM 20 is offered for women who experience insufficient physiological arousal, decreased sensitivity, or a weak genital response during intimacy. The expected effect is associated with improved local blood circulation rather than a direct impact on emotional desire. Sexual stimulation remains necessary, as tadalafil does not trigger arousal automatically. Self-administration without establishing the cause of the complaints can be ineffective and dangerous.

Sometimes the product is considered for female sexual arousal disorder, which manifests as insufficient blood flow to the genital tissues, a decrease in natural lubrication, or difficulty achieving satisfaction. However, mucosal dryness often requires other methods, including lubricants, local therapy, or correction of hormonal imbalances. TADAFEM 20 does not treat infections, vaginal pain, depression, or relationship conflicts. In the presence of such factors, targeted diagnosis and comprehensive treatment are required.

A decrease in libido on its own is not a universally recognized indication for tadalafil, as desire depends on psychological, hormonal, and social factors. The drug does not replace psychotherapy, treatment of menopausal symptoms, or review of medications that suppress sexual function. The prescription must be individual after assessing the expected benefits and potential risks. If symptoms occur suddenly, are accompanied by pain, bleeding, or severe weakness, a medical examination is required.

Composition and active components of TADAFEM 20

The active component of TADAFEM 20 is tadalafil 20 mg in one tablet. It inhibits the PDE-5 enzyme, resulting in a slower breakdown of cyclic guanosine monophosphate—a molecule that promotes the relaxation of smooth muscles in blood vessels. This can improve the blood filling of tissues in response to the natural release of nitric oxide during stimulation. Tadalafil does not directly affect sex hormone levels and does not guarantee orgasm.

The tablet may also include fillers, binders, stabilizers, colorants, and coating components. Their exact list must be verified with the official instructions and labeling of the specific package, as the composition of excipients may vary. These components form the tablet and ensure its stability, but do not create the main pharmacological effect. In case of allergies, lactose intolerance, or other excipients, prior consultation with a doctor is required.

Dosage of TADAFEM 20

TADAFEM 20 contains a high single dose of tadalafil, and a standardized regimen for its use in female sexual dysfunction has not been established. Due to the lack of a sufficient evidence base, one should not independently use regimens developed for men with erectile dysfunction. The dose, frequency, and duration can only be determined by a doctor after assessing the state of health. Exceeding one tablet within 24 hours is unacceptable, but even this frequency is not automatically recommended for women.

Tadalafil has a long-lasting effect and can remain in the body for more than 24 hours, so repeated intake can increase the risk of adverse reactions. Dose adjustment is especially important in kidney or liver diseases, low blood pressure, and the simultaneous use of drugs that affect the metabolism of tadalafil. A long-term course without medical supervision is not recommended. If there is no effect, you cannot increase the dosage on your own—you need to review the diagnosis and treatment tactics.

How to take TADAFEM 20 correctly?

The tablet is swallowed whole with a sufficient amount of water. Food usually does not have a significant effect on the absorption of tadalafil, so administration is possible regardless of meals. Do not crush the tablet or combine it with other products for sexual function without a doctor's permission. The time of administration is determined individually, taking into account the prolonged pharmacological action of the substance.

If the doctor has prescribed a regular regimen and a dose is missed, there is no need to double the next one. You should act in accordance with the individual recommendations of the specialist or clarify the procedure for administration. Before use, it is important to inform the doctor about all medical conditions, prescription drugs, over-the-counter medicines, and herbal supplements. Individual body reaction may vary, so tolerability cannot be predicted solely based on reviews from other users.

Side effects of TADAFEM 20

Common adverse reactions of tadalafil include headache, facial flushing, nasal congestion, heartburn, dyspepsia, and dizziness. Back pain, muscle pain, or limb pain are also possible, sometimes occurring several hours after administration. Usually, these manifestations are mild or moderate, but their intensity depends on the dose and individual sensitivity. If symptoms persist, use should be discontinued and a doctor consulted.

Uncommonly, palpitations, decrease or increase in blood pressure, nausea, vomiting, skin rash, blurred vision, or ringing in the ears may occur. Rare but dangerous reactions include severe allergy, chest pain, fainting, sudden loss of vision or hearing. If facial swelling, difficulty breathing, severe chest pain, or sudden sensory impairment occur, emergency medical assistance is required. You must not take nitrates on your own to relieve chest pain after taking tadalafil.

Contraindications of TADAFEM 20

An absolute contraindication is an allergy to tadalafil or any component of the tablet. TADAFEM 20 must not be combined with nitrates, nitric oxide donors, or the guanylate cyclase stimulator riociguat due to the risk of a dangerous drop in blood pressure. The product is contraindicated in conditions where sexual activity is undesirable due to severe cardiovascular disease. After a recent heart attack, stroke, with unstable angina, or uncontrolled hypotension, the decision can only be made by a doctor.

Caution is required in severe liver or kidney dysfunction, anatomical features of the genitals, retinal diseases, bleeding disorders, and peptic ulcer disease. TADAFEM 20 is not intended for children and adolescents under 18 years of age. During pregnancy and breastfeeding, use is not recommended due to the lack of adequate safety data. For elderly patients, the dose is assessed based on concomitant diseases, kidney function, and the list of other medications, rather than age alone.

Interaction of TADAFEM 20 with other drugs and alcohol

It is dangerous to combine TADAFEM 20 with nitroglycerin, isosorbide dinitrate, isosorbide mononitrate, and other nitrates. Alpha-blockers, antihypertensive drugs, and riociguat can increase the reduction in blood pressure. Some antifungal drugs, macrolide antibiotics, antiviral drugs, and grapefruit juice can increase the concentration of tadalafil, while certain anticonvulsants and rifampicin can weaken its effect. Combination with other PDE-5 inhibitors or products to enhance sexual function is not recommended.

Large amounts of alcohol increase the risk of dizziness, headache, rapid heart rate, and a sharp drop in blood pressure. Even moderate consumption should be discussed with a doctor, especially in the presence of cardiovascular diseases. If weakness, visual impairment, or dizziness occur after administration, driving and operating machinery is prohibited. Until the individual reaction is determined, it is advisable to avoid activities that require rapid reaction and high concentration.

Where to buy TADAFEM 20 in Ukraine

TADAFEM 20 may be offered in some pharmacies or online stores; however, before purchasing, it is necessary to check the state registration, the seller, the integrity of the packaging, the batch number, and the expiration date. You should avoid dubious platforms, goods without Ukrainian labeling, and documents of origin, as products for sexual function are often counterfeited. Delivery conditions must ensure protection against overheating, moisture, and damage to the packaging. The product should be stored in accordance with the instructions, in a dry place inaccessible to children, and not used after the expiration date.

Purchasing TADAFEM 20 does not replace a medical consultation and examination of the causes of sexual dysfunction. Before taking it, be sure to consult a doctor, especially in the presence of heart disease, low blood pressure, or ongoing drug therapy. The decision to use it should be based on the balance of benefits and risks, rather than promotional promises or reviews. The result and tolerability are individual, and the lack of effect requires a professional review of the treatment strategy.